Silo Pharma Inc.
(SILO)
undefined
undefined%
At close: undefined
0.84
0.76%
After-hours Dec 13, 2024, 07:32 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue,
expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
Revenue | 72.10K | 72.10K | 71.26K | 40.92K | 40.57K | - | 847.41K | -669.48K | -145.19K | -107.11K | 105.52K | - | - |
Cost of Revenue | 5.84K | 5.84K | 5.00K | 176.13K | 27.39K | 17.55K | - | - | - | -127.68K | 104.90K | - | - |
Gross Profit | 66.26K | 66.26K | 66.26K | -135.20K | 13.18K | -17.55K | 847.41K | -669.48K | -145.19K | 20.57K | 625.00 | - | - |
Operating Income | -3.86M | -3.65M | -2.74M | -2.57M | -930.40K | -594.24K | -470.39K | -393.66K | -217.17K | -248.87K | -71.99K | -39.45K | -49.80K |
Interest Income | 398.53K | 72.64K | 1.21K | 11.54K | 12.20K | 4.22K | 20.48K | 49.84K | 40.34K | 20.57K | 625.00 | - | - |
Pretax Income | -3.63M | -3.91M | 4.18M | -3.04M | -1.01M | -969.46K | 356.54K | -1.11M | -409.50K | -376.55K | 32.91K | -39.45K | -49.80K |
Net Income | -3.70M | -3.91M | 3.90M | -3.13M | -1.05M | -969.46K | 356.54K | -1.11M | -409.50K | -376.55K | 32.91K | -39.45K | -49.80K |
Selling & General & Admin | 3.08M | 2.43M | 2.27M | 2.18M | 864.18K | 459.83K | 313.37K | 300.99K | 167.70K | 269.44K | 72.61K | 39.45K | 49.80K |
Research & Development | 845.09K | 1.29M | 693.91K | 88.80K | 63.47K | - | - | - | - | - | - | - | - |
Other Expenses | - | 2.17M | 1.95M | 3.00K | 765.72K | 314.61K | 177.50K | 142.50K | 96.61K | - | - | - | - |
Operating Expenses | 3.92M | 3.71M | 2.96M | 2.27M | 927.64K | 459.83K | 490.87K | 443.49K | 264.31K | 269.44K | 72.61K | 39.45K | 49.80K |
Interest Expense | 4.87K | 2.20K | 3.04K | 269.27K | 62.93K | - | - | - | - | - | - | - | - |
Selling & Marketing Expenses | - | -1.27M | - | - | - | - | - | - | - | - | - | - | - |
Cost & Expenses | 3.93M | 3.72M | 2.96M | 2.45M | 955.03K | 459.83K | 427.96K | 443.49K | 264.31K | 269.44K | 72.61K | 39.45K | 49.80K |
Income Tax | - | 1.16K | 24.88K | 92.35K | 34.79K | -513.85K | -62.91K | 696.50K | - | - | - | - | - |
Shares Outstanding (Basic) | 3.08M | 2.28M | 1.90M | 1.32M | 842.29K | 982.03K | 1.00M | 1.00M | 1.01M | 958.30K | 648.74K | 612.62K | 612.62K |
Shares Outstanding (Diluted) | 3.08M | 2.28M | 1.92M | 1.32M | 842.29K | 982.03K | 1.04M | 1.00M | 1.01M | 958.30K | 648.74K | 612.62K | 612.62K |
EPS (Basic) | -1.2 | -1.71 | 2.06 | -2.37 | -1.24 | -0.99 | 0.50 | -1.11 | -0.4 | -0.39 | 0.05 | -0.06 | -0.08 |
EPS (Diluted) | -1.2 | -1.71 | 2.03 | -2.37 | -1.24 | -0.99 | 0.50 | -1.11 | -0.4 | -0.39 | 0.05 | -0.06 | -0.08 |
EBITDA | -3.63M | -3.91M | 4.19M | -2.39M | -930.40K | -951.91K | - | - | -217.17K | -248.87K | -71.99K | -39.45K | -49.80K |
Depreciation & Amortization | 229.38K | 72.64K | -147.29K | 179.92K | 28.14K | 17.55K | -701.10K | 719.32K | 192.33K | 127.68K | -104.90K | - | - |